Centers

FDA Oncology Center of Excellence Project Catalyst

TEST

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation

Read more

info here

Read more
Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in 2017, with the aim to facilitate advancement of academic drug discovery and drug development research by leveraging innovations and sciences...
Read more

Partnerships

Events

Jobs

Cerecor Partners with Johns Hopkins Brain Science Institute to Treat Schizophrenia

Cerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently being developed by researchers at the Johns...

 
View all

Eisiai Partners with Johns Hopkins Brain Science Institute

Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai...

 
View all

UCB To Fund "Mining the Human Microbiome" Project at Harvard

UCB as agreed to fund and support a third research project called "Mining the Human Microbiome" as part of the UCB-Harvard Research Alliance. UCB will be providing $4.5 million over a period of three years to immunologists at Harvard to study the...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All